SCHEMBL29459355

SCHEMBL29459355

O=C(O)[C@H](Cc1cccc2ccccc12)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.63
DNMT1 P26358 2/20 0.63
CYP2C19 P33261 1/20 0.63
DNMT3B Q9UBC3 1/20 0.63
PKM P14618 1/20 0.63
ALDH1A1 P00352 4/20 0.62
GAA P10253 1/20 0.62
POLB P06746 4/20 0.57
KDM4E B2RXH2 1/20 0.54
TP53 P04637 1/20 0.54
GLA P06280 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
HPGD P15428 1/20 0.54
ALOX12 P18054 1/20 0.54
NFKB1 P19838 1/20 0.54
APEX1 P27695 1/20 0.54
MAPK1 P28482 1/20 0.54
HSD17B10 Q99714 1/20 0.54
HIF1A Q16665 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28930272 1.00 KMT2A (0.63) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL28930271 1.00 KMT2A (0.63) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL23752198 0.89 L3MBTL1 (0.68) KMT2ACYP2D6L3MBTL1MEN1
SCHEMBL21068022 0.89 L3MBTL1 (0.68) KMT2ACYP2D6L3MBTL1MEN1
SCHEMBL28678717 0.88 KMT2A (0.49) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL29459444 0.88 KMT2A (0.49) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL28678716 0.88 KMT2A (0.49) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL8085365 0.84 ALDH1A1 (0.68) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL8085370 0.84 ALDH1A1 (0.68) KMT2ADNMT1CYP2C19DNMT3BPKM
SCHEMBL18258645 0.78 NPSR1 (0.59) KMT2ACYP2C19HPGDHSD17B10CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3924349-B1 AMINO ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES THE ROSKAMP INST (US) 2025-06-25 EP disclosed
US-20220081415-A1 Amino Acid Derivatives for the Treatment of Inflammatory Diseases THE ROSKAMP INST (US) 2022-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220081415-A1 Amino Acid Derivatives for the Treatment of Inflammatory Diseases NFKBIA, NFRKB, IKBKG KMT2A 2451/4885DNMT1 2271/4885CYP2C19 4522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.